Skip to main content

Recent Patents on Anti-Cancer Drug Discovery publishes review articles on recent patents in the field of anti-cancer drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.

Publisher: Bentham Science Publishers

Volume 4, Number 2, June 2009

Articles

Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer
pp. 101-109(9)
Authors: Liu, Jingjing; Gunn, Lacey; Hansen, Richard; Yan, Jun

Favourites:
ADD

Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
pp. 110-124(15)
Authors: Chang, Yu-Wen E.; Bean, Ronald R.; Jakobi, Rolf

Favourites:
ADD

Ras-MAPK Pathway as a Therapeutic Target in Cancer - Emphasis on Bladder Cancer
pp. 125-136(12)
Authors: Dangle, Pankaj P.; Zaharieva, Boriana; Jia, Hongtao; Pohar, Kamal S.

Favourites:
ADD

Paving Roads for New Drugs in Oncology
pp. 137-145(9)
Authors: Zaenker, Kurt S.; Entschladen, Frank

Favourites:
ADD

Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
pp. 146-156(11)
Authors: Seront, Emmanuel; Machiels, Jean-Pascal

Favourites:
ADD
Favourites:
ADD

Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
pp. 164-173(10)
Authors: Lee, Tai-Sung; Potts, Steven J.; Albitar, Maher

Favourites:
ADD

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer
pp. 174-179(6)
Authors: Kamath, Anil; Yoo, Dal; Stuart, Oswald A.; Bijelic, Lana; Sugarbaker, Paul H.

Favourites:
ADD
Favourites:
ADD

Patent Selections
pp. 186-188(3)
Author: Bentham Science Publishers

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more